Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 sept. 2025 08h00 HE | Source: ProPhase Labs, Inc.

ProPhase Labs Inc. to Participate in Renmark’s Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025

Company cancels the Equity Line of Credit (ELOC) UNIONDALE, NY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech,...
15 oct. 2024 19h05 HE | Source: Liqueous LP

Liqueous LP Finalizes $100 Million Equity Line of Credit With Crown Electrokinetics Corp, Building on Strategic Recapitalization Efforts and separately provides NUBURU Financing Update

DOVER, Del., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Liqueous LP, a premier multi-strategy fund specializing in liquidity solutions, is pleased to announce the finalization of a $100 million Equity Line...
07 janv. 2021 08h00 HE | Source: Tauriga Sciences

Tauriga Sciences, Inc.’s Board of Directors Unanimously Votes to Terminate Its Equity Line of Credit Due to Substantially Improved Fundamentals, Macro-Business Outlook, and Balance Sheet

NEW YORK, NY, Jan. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a...
23 janv. 2020 07h38 HE | Source: Tauriga Sciences

Tauriga Sciences Inc. Enters Into $5,000,000 Equity Line of Credit Facility to be Registered on Form S-1

Financing Agreement Supports the Company’s Ongoing Efforts to Develop Pharmaceutical Anti-Nausea Product NEW YORK, NY, Jan. 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences,...
29 juil. 2019 08h33 HE | Source: BTCS Inc.

BTCS Announces Letter to Shareholders from CEO

Balance Sheet Strengthened with $1.24m Raised in 2019 Silver Spring, MD, July 29, 2019 (GLOBE NEWSWIRE) -- BTCS Inc. (OTCQB: BTCS) (“BTCS” or the “Company”), a digital asset and blockchain...
22 avr. 2013 08h00 HE | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Secures $10 Million Funding Commitment From Lincoln Park Capital Fund, LLC

NORTHVALE, N.J., April 22, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that it has entered into a $10 million common stock purchase...